These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2848634)

  • 1. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
    Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E rosettes in the uranium miners with lung cancer.
    Kudrna K; Andrlíková J; Smíd A; Stipl Z
    Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N; Nakamura H; Tanaka Y; Ohgi S
    Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
    Kozielski J; Seweryn J
    Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CEA distribution in BALF of lung cancer patients].
    Xu WB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
    [No Abstract]   [Full Text] [Related]  

  • 13. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
    Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
    Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer].
    Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E
    Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in immunoregulatory cells in lung cancer and smoking.
    Ginns LC; Miller LG; Goldenheim PD; Goldstein G; Bria WF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):90S-94S. PubMed ID: 6982280
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
    Tatsuno I; Konishi K
    Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.